Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Risk for renal cell carcinoma in chronic hepatitis C infection.

Gordon SC, Moonka D, Brown KA, Rogers C, Huang MA, Bhatt N, Lamerato L.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1066-73. doi: 10.1158/1055-9965.EPI-09-1275. Epub 2010 Mar 23.

PMID:
20332260
[PubMed - indexed for MEDLINE]
Free Article
2.

Frequency of HCV infection in renal cell carcinoma patients.

Budakoğlu B, Aksoy S, Arslan Ç, Üyetürk Ü, Babacan NA, Özcan MF, Yıldız R, Öven BB, Özdemir NY, Dizdar Ö, Büyükberber S, Akıncı MB, Türker I, Öksüzoğlu B, Altundag K, Zengin N.

Med Oncol. 2012 Sep;29(3):1892-5. doi: 10.1007/s12032-011-9928-6. Epub 2011 Apr 3.

PMID:
21461964
[PubMed - indexed for MEDLINE]
3.

Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.

Tsui JI, Vittinghoff E, Shlipak MG, Bertenthal D, Inadomi J, Rodriguez RA, O'Hare AM.

Arch Intern Med. 2007 Jun 25;167(12):1271-6.

PMID:
17592100
[PubMed - indexed for MEDLINE]
4.

Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.

Hamada H, Yatsuhashi H, Yano K, Daikoku M, Arisawa K, Inoue O, Koga M, Nakata K, Eguchi K, Yano M.

Cancer. 2002 Jul 15;95(2):331-9.

PMID:
12124834
[PubMed - indexed for MEDLINE]
Free Article
5.

Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.

d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, Caputo SL, Arlotti M, Magnani G, Pellizzer G, Maggiolo F, Puoti M; Icona Foundation Study Group.

Clin Infect Dis. 2009 Aug 15;49(4):612-22. doi: 10.1086/603557.

PMID:
19591597
[PubMed - indexed for MEDLINE]
Free Article
6.

Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.

Bellentani S, Pozzato G, Saccoccio G, Crovatto M, Crocè LS, Mazzoran L, Masutti F, Cristianini G, Tiribelli C.

Gut. 1999 Jun;44(6):874-80.

PMID:
10323892
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis.

Satoh S, Tsuchiya N, Habuchi T, Ishiyama T, Seimo K, Kato T.

J Urol. 2005 Nov;174(5):1749-53.

PMID:
16217276
[PubMed - indexed for MEDLINE]
8.

Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.

Pereira BJ, Natov SN, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH, Levey AS.

Kidney Int. 1998 May;53(5):1374-81.

PMID:
9573555
[PubMed - indexed for MEDLINE]
Free Article
9.

Renal cell carcinoma as a cause of end-stage renal disease in the United States: patient characteristics and survival.

Stiles KP, Moffatt MJ, Agodoa LY, Swanson SJ, Abbott KC.

Kidney Int. 2003 Jul;64(1):247-53.

PMID:
12787416
[PubMed - indexed for MEDLINE]
10.

History of urinary tract infection and risk of renal cell carcinoma.

Parker AS, Cerhan JR, Lynch CF, Leibovich BC, Cantor KP.

Am J Epidemiol. 2004 Jan 1;159(1):42-8.

PMID:
14693658
[PubMed - indexed for MEDLINE]
Free Article
11.

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H.

Int J Epidemiol. 1998 Aug;27(4):574-8.

PMID:
9758109
[PubMed - indexed for MEDLINE]
Free Article
12.

Body size and renal cell cancer incidence in a large US cohort study.

Adams KF, Leitzmann MF, Albanes D, Kipnis V, Moore SC, Schatzkin A, Chow WH.

Am J Epidemiol. 2008 Aug 1;168(3):268-77. doi: 10.1093/aje/kwn122. Epub 2008 Jun 9.

PMID:
18544571
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.

Bird SM, Goldberg DJ, Hutchinson SJ.

J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.

PMID:
11437088
[PubMed - indexed for MEDLINE]
14.

Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.

Canavese C, Hollò Z, Ciccone G, Ghisetti V, Barbui A, Fop F, Martina G, Forgnone F, Novo P, Thea A, Grill A, Marchiaro G.

J Nephrol. 2000 Sep-Oct;13(5):352-9.

PMID:
11063139
[PubMed - indexed for MEDLINE]
15.

Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma.

Rabbani F, Russo P.

Urology. 1999 Jul;54(1):28-33.

PMID:
10414722
[PubMed - indexed for MEDLINE]
16.

Renal cell carcinoma in dialysis patients: a single center experience.

Kojima Y, Takahara S, Miyake O, Nonomura N, Morimoto A, Mori H.

Int J Urol. 2006 Aug;13(8):1045-8.

PMID:
16903927
[PubMed - indexed for MEDLINE]
17.

Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis.

Acalovschi M, Buzas C, Radu C, Grigorescu M.

J Viral Hepat. 2009 Dec;16(12):860-6. doi: 10.1111/j.1365-2893.2009.01141.x. Epub 2009 May 26.

PMID:
19486279
[PubMed - indexed for MEDLINE]
18.

Association of diabetes mellitus and chronic hepatitis C virus infection.

Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP.

Hepatology. 1999 Feb;29(2):328-33.

PMID:
9918906
[PubMed - indexed for MEDLINE]
19.

Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.

Gebo KA, Diener-West M, Moore RD.

J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):165-73.

PMID:
14526205
[PubMed - indexed for MEDLINE]
20.

Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.

Lai MS, Hsieh MS, Chiu YH, Chen TH.

Hepatology. 2006 Jun;43(6):1295-302.

PMID:
16729295
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk